Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China flag China · Delayed Price · Currency is CNY
34.17
-1.18 (-3.34%)
Apr 30, 2026, 9:25 AM CST

SHE:002940 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
687.41697.38859.75735.47688.91
Trading Asset Securities
102.2636.041069.359.6
Cash & Short-Term Investments
789.67733.42869.75804.76748.51
Cash Growth
7.67%-15.68%8.08%7.52%-12.36%
Accounts Receivable
218.89234.32244.86295.51301.32
Other Receivables
2.719.8521.456.7717.27
Receivables
221.6244.18266.31302.28318.59
Inventory
447.47503.79393.44293.23299.6
Other Current Assets
27.1117.4832.4351.699.25
Total Current Assets
1,4861,4991,5621,4521,376
Property, Plant & Equipment
617.28603.86615.8445.7474.63
Long-Term Investments
304.84304.7301.41302.15147.34
Goodwill
312.94312.94312.9421.9821.98
Other Intangible Assets
123.57133.55139.1438.7840.05
Long-Term Deferred Tax Assets
39.1250.0632.7722.4420.65
Long-Term Deferred Charges
52.6449.4835.060.981.6
Other Long-Term Assets
14.5721.0720.95312.091.36
Total Assets
2,9512,9753,0202,5962,084
Accounts Payable
434.09485.45402.49320.45335.97
Accrued Expenses
44.77120.24130.41220.56218.67
Short-Term Debt
137.06163.37134.9171.941.76
Current Portion of Long-Term Debt
69.7420.2130.425.02-
Current Portion of Leases
--0.26--
Current Income Taxes Payable
11.75.579.34-2.88
Current Unearned Revenue
10.4132.3118.7241.6731.9
Other Current Liabilities
105.2716.395.458.954.1
Total Current Liabilities
813.03843.54731.97788.59595.29
Long-Term Debt
242.26303.5423.95150-
Long-Term Unearned Revenue
17.6416.7817.859.7313.3
Long-Term Deferred Tax Liabilities
10.6712.2913.951.60.06
Total Liabilities
1,0841,1761,188949.93608.64
Common Stock
201.73201.73201.73139.1295.95
Additional Paid-In Capital
708.28684.01723.84782.91824.87
Retained Earnings
794.22712.9674.51577.87478.74
Treasury Stock
-84.1-74.5-20.12--63.34
Comprehensive Income & Other
7.156.46.252.752.64
Total Common Equity
1,6271,5311,5861,5031,339
Minority Interest
239.94267.87246.07143.5136.08
Shareholders' Equity
1,8671,7981,8321,6461,475
Total Liabilities & Equity
2,9512,9753,0202,5962,084
Total Debt
449.05487.08589.52346.961.76
Net Cash (Debt)
340.61246.34280.23457.8746.75
Net Cash Growth
38.27%-12.10%-38.79%-38.69%-11.34%
Net Cash Per Share
1.681.231.402.303.74
Filing Date Shares Outstanding
211.69196.89199.71197.4197.4
Total Common Shares Outstanding
211.69196.89199.71197.4197.4
Working Capital
672.82655.33829.96663.37780.67
Book Value Per Share
7.697.777.947.616.78
Tangible Book Value
1,1911,0841,1341,4421,277
Tangible Book Value Per Share
5.635.515.687.306.47
Buildings
-447.5435.42314.48319.46
Machinery
-640.01628.95467.67439.73
Construction In Progress
-49.622.5225.3329.94
Source: S&P Global Market Intelligence. Standard template. Financial Sources.